SCHEMBL13183570

SCHEMBL13183570

Cc1cccc(Cc2cnc(C(C)C)o2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ FYN P06241 3/20 0.38
▸ HTR2C P28335 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ NR3C2 P08235 1/20 0.36
▸ USP1 O94782 1/20 0.36
▸ WDR48 Q8TAF3 1/20 0.36
▸ IDO1 P14902 2/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13160094 0.85 NR3C2 (0.36) CYP11B1CYP11B2MAPTALDH1A1KDM4E
SCHEMBL13255924 0.81 CYP11B1 (0.47) CYP11B1CYP11B2MAPTALDH1A1KDM4E
SCHEMBL13255919 0.76 MEN1 (0.40) MAPTALDH1A1KDM4EMEN1NPC1
SCHEMBL823589 0.74 NPSR1 (0.38) CYP11B1CYP11B2MAPTALDH1A1KDM4E
SCHEMBL13183648 0.72 CYP11B1 (0.41) CYP11B1CYP11B2ALDH1A1MEN1NPC1
SCHEMBL22142966 0.71 FLT1 (0.47) MAPTALDH1A1KDM4ENPC1HPGD
SCHEMBL13183550 0.71 MAPT (0.50) CYP11B1CYP11B2MAPTALDH1A1KDM4E
SCHEMBL13183755 0.70 NPC1 (0.45) MAPTALDH1A1KDM4EMEN1NPC1
SCHEMBL30447931 0.70 FYN (0.41) ALDH1A1FYNHTR2CHTR2BTAAR1
SCHEMBL4505633 0.69 MAPT (0.46) CYP11B1CYP11B2MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100226882-A1 LINKED DIIMIDAZOLE ANTIVIRALS ENANTA PHARMACEUTICALS, INC. 2010-09-09 — — US disclosed
WO-2010096462-A1 LINKED DIIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC (US) 2010-08-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100226882-A1 LINKED DIIMIDAZOLE ANTIVIRALS EIF2AK2, ZC3HAV1, MAVS CYP11B1 317/4885CYP11B2 499/4885MAPT 3992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback